The global cardiovascular health supplements market size accounted for US$ 11.2 billion in 2023 and is projected to reach around USD 24.07 billion by 2033, growing at a CAGR of 8% from 2024 to 2033.
Key Points
- Asia Pacific dominated the market while contributing 39% market share in 2023.
- By type, in 2023, the natural supplements segment dominated the market with a 70% market share.
- By type, the synthetic supplements segment is expected to experience substantial growth at a CAGR of 8.13% during the forecast period.
- By ingredient, in 2023, the omega fatty acids segment dominated the market with a 31% market share.
- By ingredient, the herbs & botanicals segment is expected to grow at a CAGR of 10.34 during the forecast period.
- By form, the softgel segment dominated the market holding the largest share, 37%, in 2023.
- By form, the capsules segment is expected to grow at a CAGR of 9.95% during the forecast period.
- By distribution channel, the offline segment held the largest market share of 71% in 2023.
- By distribution channel, the online segment is observed to grow at a CAGR of 10.42% during the forecast period.
Report Summary
The global cardiovascular health supplements market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the cardiovascular health supplements market across the globe.
A comprehensive estimate on the cardiovascular health supplements market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of cardiovascular health supplements during the forecast period. Price point comparison by region with global average price is also considered in the study.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3790
Cardiovascular Health Supplements Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 8% |
| Global Market Size in 2023 | USD 11.2 Billion |
| Global Market Size by 2033 | USD 24.07 Billion |
| Largest Market | Asia Pacific |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Type, By Form, and By Distribution Channel |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized cardiovascular health supplements market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: Cybersecurity Mesh Market Size to Attain USD 8.48 Bn by 2033
Market Players
The report includes the profiles of key cardiovascular health supplements market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Recent Developments
- In September 2023, Nutrartis, a health solutions provider, introduced Cardiosmile, a supplement containing natural plant sterols, in the U.S. The liquid format offers a convenient way to support daily heart health and manage cholesterol.
- In March 2023, Life Extension, a neutraceuticals company, launched new omega-3 fish oil-based gummy bites. These sugar-free, tropical fruit-flavored chews provide potent omega-3 acids, with a high concentration of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) fatty acids in each serving.
Cardiovascular Health Supplements Market Companies
- NOW Health Group, Inc.
- Bright Lifecare Pvt Ltd (Truebasics.com)
- Natural Organics, Inc.
- DaVinci Laboratories of Vermont
- Nordic Naturals
- Thorne HealthTech, Inc.
- Nestle (Pure Encapsulations, LLC.)
- Amway
- InVite Health
- GNC Holdings, LLC
Segments Covered in the Report
By Type
- Natural Supplements
- Synthetic Supplements
- Ingredient Outlook (Revenue, USD Million, 2018 – 2030)
- Vitamins & Minerals
- Herbs & Botanicals
- Omega Fatty Acids
- Coenzyme Q10 (CoQ10)
- Others
By Form
- Liquid
- Tablet
- Capsules
- Softgels
- Powder
- Others
By Distribution Channel
- Offline
- Online
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Cardiovascular Health Supplements Market
5.1. COVID-19 Landscape: Cardiovascular Health Supplements Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Cardiovascular Health Supplements Market, By Type
8.1. Cardiovascular Health Supplements Market Revenue and Volume, by Type, 2024-2033
8.1.1 Natural Supplements
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Synthetic Supplements
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Ingredient Outlook (Revenue, USD Million, 2018 – 2030)
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Vitamins & Minerals
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
8.1.5. Herbs & Botanicals
8.1.5.1. Market Revenue and Volume Forecast (2021-2033)
8.1.6. Omega Fatty Acids
8.1.6.1. Market Revenue and Volume Forecast (2021-2033)
8.1.7. Coenzyme Q10 (CoQ10)
8.1.7.1. Market Revenue and Volume Forecast (2021-2033)
8.1.8. Others
8.1.8.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Cardiovascular Health Supplements Market, By Form
9.1. Cardiovascular Health Supplements Market Revenue and Volume, by Form, 2024-2033
9.1.1. Liquid
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Tablet
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Capsules
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
9.1.4. Softgels
9.1.4.1. Market Revenue and Volume Forecast (2021-2033)
9.1.5. Powder
9.1.5.1. Market Revenue and Volume Forecast (2021-2033)
9.1.6. Others
9.1.6.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Cardiovascular Health Supplements Market, By Distribution Channel
10.1. Cardiovascular Health Supplements Market Revenue and Volume, by Distribution Channel, 2024-2033
10.1.1. Offline
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Online
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Cardiovascular Health Supplements Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.1.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.1.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.1.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.1.4.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.1.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.1.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.2.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.2.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.2.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.2.4.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.2.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.2.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.2.6.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.2.6.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.2.7.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.2.7.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.3.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.3.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.3.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.3.4.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.3.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.3.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.3.6.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.3.6.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.3.7.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.3.7.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.4.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.4.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.4.4.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.4.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.4.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.4.6.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.4.6.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.4.7.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.4.7.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.5.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.5.4.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.5.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.5.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
Chapter 12. Company Profiles
12.1. NOW Health Group, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Bright Lifecare Pvt Ltd (Truebasics.com)
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Natural Organics, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. DaVinci Laboratories of Vermont
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Nordic Naturals
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Thorne HealthTech, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Nestle (Pure Encapsulations, LLC.)
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Amway
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. InVite Health
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. GNC Holdings, LLC
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com